메뉴 건너뛰기




Volumn 115, Issue 6, 2007, Pages 413-418

Chemokine receptor CCR5 in interferon-treated multiple sclerosis

Author keywords

interferon; CCR5; Chemokines; Immunogenetics; Monocytes; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; INTERFERON BETA SERINE;

EID: 34248640840     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00826.x     Document Type: Article
Times cited : (15)

References (31)
  • 1
    • 0342906187 scopus 로고    scopus 로고
    • Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
    • Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000 47: 707 17.
    • (2000) Ann Neurol , vol.47 , pp. 707-17
    • Lucchinetti, C.1    Bruck, W.2    Parisi, J.3    Scheithauer, B.4    Rodriguez, M.5    Lassmann, H.6
  • 2
    • 0042591142 scopus 로고    scopus 로고
    • Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system
    • Sellebjerg F, Sorensen TL. Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. Brain Res Bull 2003 61: 347 55.
    • (2003) Brain Res Bull , vol.61 , pp. 347-55
    • Sellebjerg, F.1    Sorensen, T.L.2
  • 3
    • 0033536062 scopus 로고    scopus 로고
    • CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions
    • Balashov KE, Rottman JB, Weiner HL, Hancock WW. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A 1999 96: 6873 8.
    • (1999) Proc Natl Acad Sci U S a , vol.96 , pp. 6873-8
    • Balashov, K.E.1    Rottman, J.B.2    Weiner, H.L.3    Hancock, W.W.4
  • 4
    • 0034256028 scopus 로고    scopus 로고
    • Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue
    • Simpson J, Rezaie P, Newcombe J, Cuzner ML, Male D, Woodroofe MN. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. J Neuroimmunol 2000 108: 192 200.
    • (2000) J Neuroimmunol , vol.108 , pp. 192-200
    • Simpson, J.1    Rezaie, P.2    Newcombe, J.3    Cuzner, M.L.4    Male, D.5    Woodroofe, M.N.6
  • 5
    • 0033559346 scopus 로고    scopus 로고
    • Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
    • Sorensen TL, Tani M, Jensen J et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 1999 103: 807 15.
    • (1999) J Clin Invest , vol.103 , pp. 807-15
    • Sorensen, T.L.1    Tani, M.2    Jensen, J.3
  • 6
    • 0035157253 scopus 로고    scopus 로고
    • CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis
    • Trebst C, Sorensen TL, Kivisakk P et al. CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol 2001 159: 1701 10.
    • (2001) Am J Pathol , vol.159 , pp. 1701-10
    • Trebst, C.1    Sorensen, T.L.2    Kivisakk, P.3
  • 7
    • 18544404188 scopus 로고    scopus 로고
    • Distinct chemokine receptor and cytokine expression profile in secondary progressive MS
    • Sorensen TL, Sellebjerg F. Distinct chemokine receptor and cytokine expression profile in secondary progressive MS. Neurology 2001 57: 1371 6.
    • (2001) Neurology , vol.57 , pp. 1371-6
    • Sorensen, T.L.1    Sellebjerg, F.2
  • 8
    • 0036784205 scopus 로고    scopus 로고
    • Expression of chemokine receptors in the different clinical forms of multiple sclerosis
    • Martinez-Caceres EM, Espejo C, Brieva L et al. Expression of chemokine receptors in the different clinical forms of multiple sclerosis. Mult Scler 2002 8: 390 5.
    • (2002) Mult Scler , vol.8 , pp. 390-5
    • Martinez-Caceres, E.M.1    Espejo, C.2    Brieva, L.3
  • 9
    • 0033622321 scopus 로고    scopus 로고
    • CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
    • Sellebjerg F, Madsen HO, Jensen CV, Jensen J, Garred P. CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis. J Neuroimmunol 2000 102: 98 106.
    • (2000) J Neuroimmunol , vol.102 , pp. 98-106
    • Sellebjerg, F.1    Madsen, H.O.2    Jensen, C.V.3    Jensen, J.4    Garred, P.5
  • 10
    • 0031783562 scopus 로고    scopus 로고
    • Chemokine receptors and their crucial role in human immunodeficiency virus infection: Major breakthroughs in HIV research
    • Kristiansen TB, Knudsen TB, Eugen-Olsen J. Chemokine receptors and their crucial role in human immunodeficiency virus infection: major breakthroughs in HIV research. Scand J Immunol 1998 48: 339 46.
    • (1998) Scand J Immunol , vol.48 , pp. 339-46
    • Kristiansen, T.B.1    Knudsen, T.B.2    Eugen-Olsen, J.3
  • 11
    • 0038796251 scopus 로고    scopus 로고
    • A mutated CCR5 gene may have favorable prognostic implications in MS
    • Kantor R, Bakhanashvili M, Achiron A. A mutated CCR5 gene may have favorable prognostic implications in MS. Neurology 2003 61: 238 40.
    • (2003) Neurology , vol.61 , pp. 238-40
    • Kantor, R.1    Bakhanashvili, M.2    Achiron, A.3
  • 12
    • 0035996209 scopus 로고    scopus 로고
    • Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E)
    • Schreiber K, Oturai AB, Ryder LP et al. Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E). Mult Scler 2002 8: 295 8.
    • (2002) Mult Scler , vol.8 , pp. 295-8
    • Schreiber, K.1    Oturai, A.B.2    Ryder, L.P.3
  • 13
    • 0034070679 scopus 로고    scopus 로고
    • CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group
    • Barcellos LF, Schito AM, Rimmler JB et al. CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. Immunogenetics 2000 51: 281 8.
    • (2000) Immunogenetics , vol.51 , pp. 281-8
    • Barcellos, L.F.1    Schito, A.M.2    Rimmler, J.B.3
  • 15
    • 0037180415 scopus 로고    scopus 로고
    • The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians
    • Favorova OO, Andreewski TV, Boiko AN et al. The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians. Neurology 2002 59: 1652 5.
    • (2002) Neurology , vol.59 , pp. 1652-5
    • Favorova, O.O.1    Andreewski, T.V.2    Boiko, A.N.3
  • 16
    • 2642570186 scopus 로고    scopus 로고
    • Association of CCR5 delta32 deletion with early death in multiple sclerosis
    • Gade-Andavolu R, Comings DE, MacMurray J et al. Association of CCR5 delta32 deletion with early death in multiple sclerosis. Genet Med 2004 6: 126 31.
    • (2004) Genet Med , vol.6 , pp. 126-31
    • Gade-Andavolu, R.1    Comings, D.E.2    MacMurray, J.3
  • 17
    • 2342469322 scopus 로고    scopus 로고
    • Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis
    • Pulkkinen K, Luomala M, Kuusisto H et al. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis. Acta Neurol Scand 2004 109: 342 7.
    • (2004) Acta Neurol Scand , vol.109 , pp. 342-7
    • Pulkkinen, K.1    Luomala, M.2    Kuusisto, H.3
  • 18
    • 3042741204 scopus 로고    scopus 로고
    • Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course
    • Silversides JA, Heggarty SV, McDonnell GV, Hawkins SA, Graham CA. Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course. Mult Scler 2004 10: 149 52.
    • (2004) Mult Scler , vol.10 , pp. 149-52
    • Silversides, J.A.1    Heggarty, S.V.2    McDonnell, G.V.3    Hawkins, S.A.4    Graham, C.A.5
  • 20
    • 0035212393 scopus 로고    scopus 로고
    • Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta
    • Zang YC, Halder JB, Samanta AK, Hong J, Rivera VM, Zhang JZ. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta. J Neuroimmunol 2001 112: 174 80.
    • (2001) J Neuroimmunol , vol.112 , pp. 174-80
    • Zang, Y.C.1    Halder, J.B.2    Samanta, A.K.3    Hong, J.4    Rivera, V.M.5    Zhang, J.Z.6
  • 21
    • 18844482559 scopus 로고    scopus 로고
    • Interferon-beta 1a does not reduce expression of CCR5 and CXCR3 on circulating T cells
    • Kivisakk P, Cotleur AC, Lee JC, Rudick RA, Ransohoff RM. Interferon-beta 1a does not reduce expression of CCR5 and CXCR3 on circulating T cells. J Neuroimmunol 2003 141: 150 4.
    • (2003) J Neuroimmunol , vol.141 , pp. 150-4
    • Kivisakk, P.1    Cotleur, A.C.2    Lee, J.C.3    Rudick, R.A.4    Ransohoff, R.M.5
  • 22
    • 4444251943 scopus 로고    scopus 로고
    • Selective suppression of chemokine receptor CXCR3 expression by interferon-beta1a in multiple sclerosis
    • Sorensen TL, Sellebjerg F. Selective suppression of chemokine receptor CXCR3 expression by interferon-beta1a in multiple sclerosis. Mult Scler 2002 8: 104 7.
    • (2002) Mult Scler , vol.8 , pp. 104-7
    • Sorensen, T.L.1    Sellebjerg, F.2
  • 23
    • 0038546727 scopus 로고    scopus 로고
    • Microarray analysis identifies interferon beta-regulated genes in multiple sclerosis
    • Koike F, Satoh J, Miyake S et al. Microarray analysis identifies interferon beta-regulated genes in multiple sclerosis. J Neuroimmunol 2003 139: 109 18.
    • (2003) J Neuroimmunol , vol.139 , pp. 109-18
    • Koike, F.1    Satoh, J.2    Miyake, S.3
  • 24
    • 0034855936 scopus 로고    scopus 로고
    • Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes
    • Wandinger KP, Sturzebecher CS, Bielekova B et al. Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann Neurol 2001 50: 349 57.
    • (2001) Ann Neurol , vol.50 , pp. 349-57
    • Wandinger, K.P.1    Sturzebecher, C.S.2    Bielekova, B.3
  • 25
    • 33745868391 scopus 로고    scopus 로고
    • Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis
    • Krakauer M, Sorensen PS, Khademi M, Olsson T, Sellebjerg F. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis. Scand J Immunol 2006 64: 155 63.
    • (2006) Scand J Immunol , vol.64 , pp. 155-63
    • Krakauer, M.1    Sorensen, P.S.2    Khademi, M.3    Olsson, T.4    Sellebjerg, F.5
  • 26
    • 3142661927 scopus 로고    scopus 로고
    • Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning
    • Wysocki CA, Burkett SB, Panoskaltsis-Mortari A et al. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. J Immunol 2004 173: 845 54.
    • (2004) J Immunol , vol.173 , pp. 845-54
    • Wysocki, C.A.1    Burkett, S.B.2    Panoskaltsis-Mortari, A.3
  • 27
    • 2342486058 scopus 로고    scopus 로고
    • Chemokine inhibition-why, when, where, which and how?
    • Johnson Z, Power CA, Weiss C et al. Chemokine inhibition-why, when, where, which and how? Biochem Soc Trans 2004 32 (Pt 2 366 77.
    • (2004) Biochem Soc Trans , vol.32 , Issue.2 , pp. 366-77
    • Johnson, Z.1    Power, C.A.2    Weiss, C.3
  • 28
    • 0021035886 scopus 로고
    • Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS)
    • Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983 33: 1444 52.
    • (1983) Neurology , vol.33 , pp. 1444-52
    • Kurtzke, J.F.1
  • 29
    • 0034955141 scopus 로고    scopus 로고
    • Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis
    • McDonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 50: 121 7.
    • (2001) Ann Neurol , vol.50 , pp. 121-7
    • McDonald, W.I.1    Compston, A.2    Edan, G.3
  • 30
    • 0035371942 scopus 로고    scopus 로고
    • A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression
    • Kristiansen TB, Knudsen TB, Ohlendorff S, Eugen-Olsen J. A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression. J Immunol Methods 2001 252: 147 51.
    • (2001) J Immunol Methods , vol.252 , pp. 147-51
    • Kristiansen, T.B.1    Knudsen, T.B.2    Ohlendorff, S.3    Eugen-Olsen, J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.